🇺🇸 FDA
Pipeline program

MAU868

MAU868-201

Phase 2 small_molecule completed

Quick answer

MAU868 for BK Virus Infection is a Phase 2 program (small_molecule) at Vera Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Vera Therapeutics
Indication
BK Virus Infection
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials